AdBIOPRO Symposium 2025
AdBIOPRO, VINNOVA Competence Centre for Advanced BioProduction by Continuous Processing, organizes a symposium, AdBIOPRO Symposium 2025 - Bioproduction of Therapeutic Biologics including ATMP’s, in Stockholm.
We would like to invite you to this event and welcome you to submit an abstract for a presentation, oral or poster, to join the presenters already registered. As previously, the theme will be Bioproduction of Therapeutic Biologics, covering process development, formulation, characterization, for biologics such as proteins, viral vectors, cells, etc. will feature achievements of the Competence Centre AdBIOPRO and will be a great opportunity for networking.
Time and place
Time: 13th of Oct 9:30 to 18:00 (and optional dinner) and 14th of Oct 8:30 to 12:30, 2025.
Venue: KTH, AlbaNova Centre, Roslagstullsbacken 21, SE114 21 Stockholm, Sweden
Register for the AdBIOPRO Symposium 2025
Contact for questions and inquiries: Sofia Renblad and Veronique Chotteau , please mention AdBIOPRO2025 Symposium.
We are looking forward to meeting you at the AdBIOPRO Symposium 2025!
Preliminary program
Engineering AAV vectors: improving efficiency and vector genome cargo size - Ana Coroadinha, iBET, Portugal
Heterogeneity in an Adeno-Associated Virus transfection-based production process limits the production efficiency - Sofia Tunmats, KTH
Adeno-associated virus production intensification by continuous bioprocess with repeated transfections in high cell-density perfusion bioreactors - Ye Zhang, KTH
Enhancing rAAV yield through mixer-based optimization of transient transfection for scalable gene therapy production - Brian Ladd, KTH
Removal of inhibitory compounds from high cell density cultures for transient production of rAAV - William Larsson, KTH
Biofabrication strategies of 3D in vitro tissue and disease models, and materials for cell transplantation for wound healing - Daniel Aili, Linköping University
Perfusion Process for the expansion of human mesenchymal stromal cells scale-up at pilot scale - Johanna Pechan, KTH and CellColabs
Automated large-scale expansion of gene-modified natural killer cells for allogeneic cell therapy - Stefanie Renken, Karolinska Institute
Automating iPSC expansion using hollow-fibre perfusion technology - Sophia Borate, Karolinska Institute
Engineering of mammalian cell factories for production of challenging biologics - Magdalena Malm, KTH
Biolaminin as a Defined Substrate for Automated Cell Culture at Scale - Evan Lee Graham, BioLamina
HEK293 aggregates as model for optimizing stem cell bioprocessing parameters - Meeri Mäkinen, KTH
Industrial production of ATMPs, from research to GMP: the development journey to the clinic - Michael Delahaye, CCRM Nordic
Risks for ATMP induced tumorigenicity from a regulatory perspective - Björn Carlsson, SSI Strategy
Model-based feed-medium optimization for mAb yield maximization produced by CHO cells under perfusion culture - Kévin Colin, Université de Lorraine, France
Downstream purification strategies for complex antibodies - Andreas Jonsson, Cytiva
Integration of buffer recycling in advanced antibody downstream processes - Julius Klemens Lorek, Lund University
Digital bioprocessing using electro-responsive brushes - Gustav Ferrand-Drake del Castillo, Nyctea Technologies
Enhancing biomanufacturing: A scaled-down continuous centrifuge for efficient cell harvesting and technology transfer - Michaela Dölle, KTH and AlfaLaval
Biosimilar development – Alvotech, a world leading biosimilar company investing in a growing R&D hub in Stockholm - David Vikström, Alvotech (title to be announced)
